146 related articles for article (PubMed ID: 31740718)
21. DARPP-32 40 years later.
Girault JA; Nairn AC
Adv Pharmacol; 2021; 90():67-87. PubMed ID: 33706939
[TBL] [Abstract][Full Text] [Related]
22. t-Darpp promotes cancer cell survival by up-regulation of Bcl2 through Akt-dependent mechanism.
Belkhiri A; Dar AA; Zaika A; Kelley M; El-Rifai W
Cancer Res; 2008 Jan; 68(2):395-403. PubMed ID: 18199533
[TBL] [Abstract][Full Text] [Related]
23. Dopamine and cAMP regulated phosphoprotein MW 32 kDa is overexpressed in early stages of gastric tumorigenesis.
Mukherjee K; Peng D; Brifkani Z; Belkhiri A; Pera M; Koyama T; Koehler EA; Revetta FL; Washington MK; El-Rifai W
Surgery; 2010 Aug; 148(2):354-63. PubMed ID: 20580047
[TBL] [Abstract][Full Text] [Related]
24. A Homozygous Missense Variant in PPP1R1B/DARPP-32 Is Associated With Generalized Complex Dystonia.
Khan A; Molitor A; Mayeur S; Zhang G; Rinaldi B; Lannes B; Lhermitte B; Umair M; Arold ST; Friant S; Rastegar S; Anheim M; Bahram S; Carapito R
Mov Disord; 2022 Feb; 37(2):365-374. PubMed ID: 34820905
[TBL] [Abstract][Full Text] [Related]
25. Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression.
Kunii Y; Hyde TM; Ye T; Li C; Kolachana B; Dickinson D; Weinberger DR; Kleinman JE; Lipska BK
Mol Psychiatry; 2014 Feb; 19(2):192-9. PubMed ID: 23295814
[TBL] [Abstract][Full Text] [Related]
26. Human t-DARPP is induced during striatal development.
Straccia M; Carrere J; Rosser AE; Canals JM
Neuroscience; 2016 Oct; 333():320-30. PubMed ID: 27475250
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
Koutras A; Lazaridis G; Koliou GA; Kouvatseas G; Christodoulou C; Pectasides D; Kotoula V; Batistatou A; Bobos M; Tsolaki E; Papadopoulou K; Pentheroudakis G; Papakostas P; Pervana S; Petraki K; Chrisafi S; Razis E; Psyrri A; Bafaloukos D; Kalogeras KT; Kalofonos HP; Fountzilas G
PLoS One; 2018; 13(12):e0207707. PubMed ID: 30521571
[TBL] [Abstract][Full Text] [Related]
28. DRD2/DARPP-32 expression correlates with lymph node metastasis and tumor progression in patients with esophageal squamous cell carcinoma.
Li L; Miyamoto M; Ebihara Y; Mega S; Takahashi R; Hase R; Kaneko H; Kadoya M; Itoh T; Shichinohe T; Hirano S; Kondo S
World J Surg; 2006 Sep; 30(9):1672-9; discussion 1680-1. PubMed ID: 16850143
[TBL] [Abstract][Full Text] [Related]
29. Reduced prefrontal cortex DARPP-32 mRNA in completed suicide victims with schizophrenia.
Feldcamp LA; Souza RP; Romano-Silva M; Kennedy JL; Wong AH
Schizophr Res; 2008 Aug; 103(1-3):192-200. PubMed ID: 18573638
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab.
Lee HJ; Kim JY; Park SY; Park IA; Song IH; Yu JH; Ahn JH; Gong G
Am J Clin Pathol; 2015 Oct; 144(4):570-8. PubMed ID: 26386078
[TBL] [Abstract][Full Text] [Related]
32.
Zhu S; Soutto M; Chen Z; Peng D; Romero-Gallo J; Krishna US; Belkhiri A; Washington MK; Peek R; El-Rifai W
Gut; 2017 May; 66(5):761-762. PubMed ID: 27590997
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant treatment with trastuzumab and pertuzumab plus palbociclib and fulvestrant in HER2-positive, ER-positive breast cancer (NA-PHER2): an exploratory, open-label, phase 2 study.
Gianni L; Bisagni G; Colleoni M; Del Mastro L; Zamagni C; Mansutti M; Zambetti M; Frassoldati A; De Fato R; Valagussa P; Viale G
Lancet Oncol; 2018 Feb; 19(2):249-256. PubMed ID: 29326029
[TBL] [Abstract][Full Text] [Related]
34. Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition.
Meyer-Lindenberg A; Straub RE; Lipska BK; Verchinski BA; Goldberg T; Callicott JH; Egan MF; Huffaker SS; Mattay VS; Kolachana B; Kleinman JE; Weinberger DR
J Clin Invest; 2007 Mar; 117(3):672-82. PubMed ID: 17290303
[TBL] [Abstract][Full Text] [Related]
35. DARPP-32 (dopamine and 3',5'-cyclic adenosine monophosphate-regulated neuronal phosphoprotein) is essential for the maintenance of thyroid differentiation.
García-Jiménez C; Zaballos MA; Santisteban P
Mol Endocrinol; 2005 Dec; 19(12):3060-72. PubMed ID: 16020482
[TBL] [Abstract][Full Text] [Related]
36. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
37. t-Darpp is an elongated monomer that binds calcium and is phosphorylated by cyclin-dependent kinases 1 and 5.
Momand J; Magdziarz P; Feng Y; Jiang D; Parga E; Celis A; Denny E; Wang X; Phillips ML; Monterroso E; Kane SE; Zhou F
FEBS Open Bio; 2017 Sep; 7(9):1328-1337. PubMed ID: 28904862
[TBL] [Abstract][Full Text] [Related]
38. Trastuzumab and survival of patients with metastatic breast cancer.
Kast K; Schoffer O; Link T; Forberger A; Petzold A; Niedostatek A; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
Arch Gynecol Obstet; 2017 Aug; 296(2):303-312. PubMed ID: 28616827
[TBL] [Abstract][Full Text] [Related]
39. DARPP-32 is required for MAPK/ERK signaling in thyroid cells.
Chocarro-Calvo A; Zaballos MA; Santisteban P; García-Jiménez C
Mol Endocrinol; 2012 Mar; 26(3):471-80. PubMed ID: 22301787
[TBL] [Abstract][Full Text] [Related]
40. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
Xian D; Zhao Y
J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
